Edgewise Therapeutics, Inc. Insider Transactions
Edgewise Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 100,000 @ $27.37 | $2.74 M | 14,863 | 12/30/2024 | 12/31/2024 | |
|
Semigran Marc
Chief Development Officer |
Sell | 1,729 @ $30.08 | $52,009 | 6,716 | 12/24/2024 | 12/27/2024 | |
|
Semigran Marc
Chief Development Officer |
Sell | 27,980 @ $29.66 | $829,906 | 8,445 | 12/24/2024 | 12/27/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 20,922 @ $27.63 | $578,064 | 3,252 | 09/23/2024 | 09/24/2024 | |
| Sell | 4,064 @ $28.59 | $116,174 | 31,864 | 09/20/2024 | 09/24/2024 | ||
| Sell | 50,000 @ $28.55 | $1.43 M | 6,904 | 09/20/2024 | 09/24/2024 | ||
| Sell | 46,068 @ $28.59 | $1.32 M | 35,928 | 09/20/2024 | 09/24/2024 | ||
| Sell | 7,162 @ $28.29 | $202,603 | 14,538 | 09/20/2024 | 09/24/2024 | ||
| Sell | 24,960 @ $28.59 | $713,512 | 6,904 | 09/20/2024 | 09/24/2024 | ||
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 815 @ $29.51 | $24,049 | 12,719 | 09/20/2024 | 09/24/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 50,000 @ $28.37 | $1.42 M | 3,252 | 09/20/2024 | 09/24/2024 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 42,068 @ $29.03 | $1.22 M | 15,121 | 09/20/2024 | 09/24/2024 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 74,185 @ $28.25 | $2.10 M | 13,534 | 09/20/2024 | 09/24/2024 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 1,576 @ $18.91 | $29,802 | 7,238 | 05/02/2024 | 05/03/2024 | |
| Sell | 2,157 @ $18.91 | $40,789 | 35,230 | 05/02/2024 | 05/03/2024 | ||
|
KOCH KEVIN
CEO |
Sell | 3,152 @ $18.91 | $59,604 | 14,478 | 05/02/2024 | 05/03/2024 | |
| Sell | 3,682 @ $18.91 | $69,627 | 19,897 | 05/02/2024 | 05/03/2024 | ||
|
Derakhshan Behrad
Chief Business Officer |
Sell | 1,718 @ $18.91 | $32,487 | 13,422 | 05/02/2024 | 05/03/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 1,956 @ $18.91 | $36,988 | 3,252 | 05/02/2024 | 05/03/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 8,029 @ $20.01 | $160,657 | 0 | 02/09/2024 | 02/09/2024 |
Edgewise Therapeutics, Inc. FAQ's
Who is on Edgewise Therapeutics, Inc.'s Insider Roster?
The list of insiders at Edgewise Therapeutics, Inc. includes ORBIMED ADVISORS LLC, Thompson Peter A., Carruthers R Michael, Derakhshan Behrad, MOORE JOHN R, Donovan Joanne M., Russell Alan J, KOCH KEVIN, Semigran Marc.
How much insider selling is happening at Edgewise Therapeutics, Inc.?
Insiders have sold a total of 594,029 Edgewise Therapeutics, Inc. shares in the last 12 months for a total of 15.22 M sold.
Which Edgewise Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Edgewise Therapeutics, Inc. shares in the last 12 months: Carruthers R Michael ($5.03 M), Derakhshan Behrad ($1.45 M), MOORE JOHN R ($2.63 M), Donovan Joanne M. ($272,230), Russell Alan J ($4.89 M), KOCH KEVIN ($59,604), Semigran Marc ($881,915),
How much insider buying is happening at Edgewise Therapeutics, Inc.?
Insiders have purchased a total of 909,090 Edgewise Therapeutics, Inc. shares in the last 12 months for a total of 10.00 M.
Which Edgewise Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Edgewise Therapeutics, Inc. shares in the last 12 months: ORBIMED ADVISORS LLC ($5.00 M), Thompson Peter A. ($5.00 M),